Not applicableStudy completedNCT05747274What this trial is testingSRDK0921_ Analytical Performance StudyWho this might be right forKidney Transplant Rejection BioMAdvanced Diagnostics 439
Large-scale testing (Phase 3)Study completedNCT00470665What this trial is testingStudy Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant RecipientsWho this might be right forRenal Allograft Recipients Wyeth is now a wholly owned subsidiary of Pfizer 460
Large-scale testing (Phase 3)Study completedNCT01680861What this trial is testingTacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate SodiumWho this might be right forTransplant; Failure, Kidney Gaetano Ciancio 32
Large-scale testing (Phase 3)Study completedNCT00975000What this trial is testingTreatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsWho this might be right forChronic Allograft NephropathyChronic Kidney DiseaseChronic Renal Failure+7 more Amgen 114
Not applicableActive Not RecruitingNCT05477082What this trial is testingBlood Biomarkers in Pediatric Kidney Transplant RecipientsWho this might be right forRejection of Kidney Allograft University of Minnesota 27
Testing effectiveness (Phase 2)Study completedNCT00446459What this trial is testingEffects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.Who this might be right forKidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more University of Washington 45
Post-approval studies (Phase 4)Study completedNCT00282217What this trial is testingStudy Evaluating Sirolimus in the Treatment of Kidney TransplantWho this might be right forKidney FailureKidney Diseases Wyeth is now a wholly owned subsidiary of Pfizer 100
Not applicableStudy completedNCT07004660What this trial is testingPerformances of Large Language Models in Kidney Allograft DiagnosticsWho this might be right forKidney Transplantation Paris Translational Research Center for Organ Transplantation 240
Post-approval studies (Phase 4)Study completedNCT00188955What this trial is testingPilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney TransplantWho this might be right forKidney Transplantation University of Manitoba 40
Post-approval studies (Phase 4)Study completedNCT00476164What this trial is testingStudy of Rituximab to Treat Chronic Renal Transplant RejectionWho this might be right forKidney TransplantationGraft RejectionImmunosuppression King's College London 62
Testing effectiveness (Phase 2)UnknownNCT00498160What this trial is testingInduction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell InfusionWho this might be right forRenal Failure Talaris Therapeutics Inc. 38
Testing effectiveness (Phase 2)Ended earlyNCT04335578What this trial is testingEvaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Zampilimab in Adult Kidney Transplant Recipients With Chronic Allograft InjuryWho this might be right forChronic Allograft Injury UCB Biopharma SRL 3
Post-approval studies (Phase 4)UnknownNCT00693446What this trial is testingCompare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus CorticosteroidsWho this might be right forPancreas TransplantationKidney Transplantation Nantes University Hospital 118
Not applicableStudy completedNCT01093703What this trial is testingChronotherapy Versus Conventional BP Control to Correct Abnormal Circadian BP Pattern in Kidney Transplant RecipientsWho this might be right forBlood Pressure ControlKidney Transplant Recipient Mayo Clinic 99
Post-approval studies (Phase 4)Study completedNCT00634920What this trial is testingEvaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant RecipientsWho this might be right forRenal Function Novartis Pharmaceuticals 204
Testing effectiveness (Phase 2)Study completedNCT00307125What this trial is testingRituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA AlloantibodiesWho this might be right forKidney TransplantKidney Transplant RecipientGraft Function/Survival+1 more National Institute of Allergy and Infectious Diseases (NIAID) 757
Large-scale testing (Phase 3)Ended earlyNCT00137345What this trial is testingStudy Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant RecipientsWho this might be right forKidney Transplant Wyeth is now a wholly owned subsidiary of Pfizer 500
Post-approval studies (Phase 4)Study completedNCT01820897What this trial is testingEfficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney TransplantationWho this might be right forUrinary Tract InfectionAsymptomatic BacteriuriaAllograft Rejection+2 more JOSE MANUEL ARREOLA GUERRA 130
Large-scale testing (Phase 3)Study completedNCT00478608What this trial is testingStudy Evaluating Rapamune® Maintenance RegimenWho this might be right forRenal Transplant Wyeth is now a wholly owned subsidiary of Pfizer 79
Testing effectiveness (Phase 2)Study completedNCT01294020What this trial is testingStudy to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®Who this might be right forIntestine TransplantationKidney TransplantationLung Transplantation+2 more Astellas Pharma Europe Ltd. 81